Associated Papers
Development of a Technique for Diagnosis and Screening of Superficial Bladder Cancer by Cell-Pellet DNA From Urine Sample.
Seok J et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2025
Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations.
Lima NC et al.
International Journal of Molecular Sciences, 2020
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.
Batista R et al.
Frontiers in Genetics, 2019
Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities.
Pommier SJ et al.
Annals of Surgical Oncology, 2012
21748247 (PubMed )
Supplement: 10434_2011_1892_MOESM2_ESM.pdf
Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg).
Andreou A et al.
American Journal of Medical Genetics. Part A, 2006
Select a paper to view details